Short Interest in Hypermarcas (OTCMKTS:HYPMY) Drops By 94.7%

Hypermarcas (OTCMKTS:HYPMY) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,352 shares, a drop of 94.7% from the April 30th total of 63,443 shares. Based on an average trading volume of 57,615 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Hypermarcas Price Performance

OTCMKTS HYPMY traded down $0.05 during trading hours on Friday, hitting $4.35. The company had a trading volume of 25,212 shares, compared to its average volume of 25,481. Hypermarcas has a 52 week low of $3.71 and a 52 week high of $5.50. The firm has a 50 day simple moving average of $4.53 and a 200 day simple moving average of $4.51. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27. The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of 9.06 and a beta of 0.73.

Hypermarcas (OTCMKTS:HYPMY) last issued its earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The business had revenue of $383.13 million during the quarter. Equities research analysts expect that Hypermarcas will post 0.53 earnings per share for the current year.

Analyst Ratings Changes

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.